ATE473749T1 - Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration - Google Patents

Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration

Info

Publication number
ATE473749T1
ATE473749T1 AT00952141T AT00952141T ATE473749T1 AT E473749 T1 ATE473749 T1 AT E473749T1 AT 00952141 T AT00952141 T AT 00952141T AT 00952141 T AT00952141 T AT 00952141T AT E473749 T1 ATE473749 T1 AT E473749T1
Authority
AT
Austria
Prior art keywords
rhamnolipids
prevention
treatment
wound healing
gum disease
Prior art date
Application number
AT00952141T
Other languages
English (en)
Inventor
Tamara Stipcevic
Tihana Piljac
Jasenka Piljac
Tatjana Dujmic
Goran Piljac
Original Assignee
Paradigm Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paradigm Biomedical Inc filed Critical Paradigm Biomedical Inc
Application granted granted Critical
Publication of ATE473749T1 publication Critical patent/ATE473749T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00952141T 1999-08-05 2000-08-07 Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration ATE473749T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14726599P 1999-08-05 1999-08-05
PCT/US2000/017875 WO2001010447A1 (en) 1999-08-05 2000-08-07 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration

Publications (1)

Publication Number Publication Date
ATE473749T1 true ATE473749T1 (de) 2010-07-15

Family

ID=22520899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952141T ATE473749T1 (de) 1999-08-05 2000-08-07 Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration

Country Status (7)

Country Link
US (1) US7129218B2 (de)
EP (1) EP1200100B1 (de)
AT (1) ATE473749T1 (de)
AU (1) AU6489300A (de)
CA (1) CA2378557C (de)
DE (1) DE60044674D1 (de)
WO (1) WO2001010447A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660055A1 (fr) * 1990-03-26 1991-09-27 Serva Soc Dispositif de filtration et de stabilisation de pression pour installation de ventilation a debit variable.
EP2074889A4 (de) * 2006-10-17 2013-10-30 Idemitsu Kosan Co Tierfutteradditiv und tierfutter
WO2009038110A1 (ja) * 2007-09-19 2009-03-26 Nagoya Industrial Science Research Institute 神経栄養因子様作用剤
US20090187484A1 (en) * 2008-01-18 2009-07-23 Cleareso, Llc Soil treatments with carbon dioxide
US20090186767A1 (en) * 2008-01-18 2009-07-23 Cleareso, Llc Use of surfactants for mitigating damage to plants from pests
US20090186761A1 (en) * 2008-01-18 2009-07-23 Cleareso, Llc Use of bio-derived surfactants for mitigating damage to plants from pests
US20100115833A1 (en) * 2008-11-10 2010-05-13 Green Knight Technologies, Llc Soil treatments with greenhouse gas
US8592381B2 (en) * 2008-12-18 2013-11-26 Rhamnopharma Inc. Method for treating rhinitis and sinusitis by rhamnolipids
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
CN103347529B (zh) 2010-12-09 2016-10-26 Y&B妈妈之选有限公司 包含皂苷的制剂及其用途
WO2012077120A2 (en) 2010-12-09 2012-06-14 Y&B Mother's Choice Ltd. Natural formulations
DE102013205756A1 (de) 2013-04-02 2014-10-02 Evonik Industries Ag Mischungszusammensetzung enthaltend Rhamnolipide
EP2786742A1 (de) * 2013-04-02 2014-10-08 Evonik Industries AG Kosmetika enthaltend Rhamnolipide
WO2015030702A2 (en) * 2013-08-26 2015-03-05 Keith Desanto High purity rhamnolipid cosmetic application
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
CN105326848A (zh) * 2015-11-26 2016-02-17 浙江大学 一种鼠李糖脂在制备抗纤维化药物制剂中的用途
US10676495B2 (en) 2016-02-22 2020-06-09 Evonik Operations Gmbh Rhamnolipid esters as nonionic surfactants for cosmetic use
CN110267641A (zh) * 2017-02-10 2019-09-20 赢创德固赛有限公司 含有至少一种生物表面活性剂和氟化物的口腔护理组合物
US11696885B2 (en) * 2017-08-24 2023-07-11 Evonik Operations Gmbh Rhamnolipid derivatives as emulsifiers and dispersing aids
EP3731804A4 (de) * 2017-12-28 2022-01-05 Locus IP Company, LLC Zusammensetzung für die mundgesundheit mit gereinigten biotensiden und / oder ihren derivaten
WO2022017844A1 (en) 2020-07-22 2022-01-27 Evonik Operations Gmbh New rhamnolipid oligo-esters
EP4015588A1 (de) 2020-12-15 2022-06-22 Evonik Operations GmbH Verwendung von rhamnolipiden und/oder sophorolipiden in beschichtungszusammensetzungen zur erhaltung eines homogenen farbbildes des trockenen beschichtungsfilms und/oder zur erhöhung der arbeitssicherheit bei der herstellung von beschichtungszusammensetzungen
EP4015583A1 (de) 2020-12-15 2022-06-22 Evonik Operations GmbH Verwendung von rhamnolipiden und/oder sophorolipiden zur erhöhung der ergiebigkeit und/oder zur erhaltung der applikationseigenschaften bei lagerung von beschichtungszusammensetzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5466675A (en) 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
BE1005704A4 (nl) * 1992-02-04 1993-12-21 Piljac Goran & Piljac Visnja Farmaceutisch preparaat op basis van rhamnolipide.
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
EP1056462B1 (de) * 1998-02-24 2007-07-25 Paradigm Biomedical Inc. Verwendundung von Rhamnolipiden als Kosmetika

Also Published As

Publication number Publication date
WO2001010447A1 (en) 2001-02-15
AU6489300A (en) 2001-03-05
US7129218B2 (en) 2006-10-31
DE60044674D1 (de) 2010-08-26
US20040224905A1 (en) 2004-11-11
EP1200100A4 (de) 2004-05-19
EP1200100A1 (de) 2002-05-02
CA2378557A1 (en) 2001-02-15
CA2378557C (en) 2009-12-08
EP1200100B1 (de) 2010-07-14

Similar Documents

Publication Publication Date Title
ATE473749T1 (de) Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
DE59712501D1 (de) 1-benzyl-3-(substituiertes-hetaryl)-kondensierten pyrazol-derivaten zur behandlung von erkrankungen des herz-kreislaufsystems und des zentralnervensystems
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
DE50206297D1 (de) Arzneimittel auf Basis von Gestagenen zur dermalen Anwendung enthaltend Ascorbinsäure sowie deren Salze
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
ATE452640T1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
ATE212351T1 (de) Androsten-derivate
ATE220918T1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
SE9802208D0 (sv) Novel compounds
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
SE9802209D0 (sv) Novel compounds
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
BR0016720A (pt) Uso de trimebutina para tratamento de dores
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
MX9705592A (es) Composiciones farmaceuticas que contienen corticosteroides y preparacion de las mismas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties